MARKET

WVE

WVE

Wave Life Scienc
NASDAQ
4.410
+0.320
+7.82%
After Hours: 4.400 -0.01 -0.23% 18:47 02/23 EST
OPEN
4.070
PREV CLOSE
4.090
HIGH
4.440
LOW
4.010
VOLUME
1.01M
TURNOVER
0
52 WEEK HIGH
6.94
52 WEEK LOW
3.150
MARKET CAP
525.40M
P/E (TTM)
-5.0842
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at WVE last week (0212-0216)?
Weekly Report · 02/19 09:56
Weekly Report: what happened at WVE last week (0205-0209)?
Weekly Report · 02/12 09:51
Weekly Report: what happened at WVE last week (0129-0202)?
Weekly Report · 02/05 09:55
Strategic Investment Boosts Wave Life Sciences: A Buy Rating Amidst Market Underappreciation
TipRanks · 02/01 06:18
$16.5M Bet On This Healthcare Stock? Check Out These 4 Stocks Insiders Are Buying
U.S. Stocks closed mixed on Tuesday. There were a few notable insider trades. Intel Corporation CEO bought a total of 3,000 shares at an average price of $43.36. Wave Life Sciences Ltd. And Corbus Pharmaceuticals Holdings, Inc. Made notable insider purchases.
Benzinga · 01/31 13:31
POWL, AMSC and MANH are among after hour movers
Seeking Alpha · 01/30 22:31
Weekly Report: what happened at WVE last week (0122-0126)?
Weekly Report · 01/29 09:51
Salim Syed Endorses Wave Life Sciences with a Buy Rating on RNA Editing Therapies’ Potential
TipRanks · 01/22 20:20
More
About WVE
Wave Life Sciences Ltd. is a clinical-stage genetic medicines company. The Company is engaged in developing medicines across multiple therapeutic modalities using PRISM, its proprietary discovery and drug development platform that enables the precise design, optimization, and production of stereopure oligonucleotides. The Company’s ribonucleic acid (RNA)-targeting oligonucleotides is designed to correct disease-causing mutations, modulate protein activity, restore the production of functional proteins, or reduce the expression of disease-promoting RNAs or proteins. Its lead programs are designed to treat genetic diseases, including those in muscle, including Duchenne muscular dystrophy (DMD); liver, including alpha-1 antitrypsin deficiency (AATD); and the central nervous system (CNS), including Huntington’s disease (HD), amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). These programs include WVE-N531, WVE-006, WVE-003, and WVE-004.

Webull offers Wave Life Sciences Ltd stock information, including NASDAQ: WVE real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, WVE stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading WVE stock methods without spending real money on the virtual paper trading platform.